Scientific Publications by FDA Staff

J Biol Chem 2014 Oct 17;289(42):29247-60

First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification.

Saá P, Yakovleva O, De Castro J, Vasilyeva I, De Paoli SH, Simak J, Cervenakova L

The development of variant Creutzfeldt-Jakob disease (vCJD) in three recipients of non-leukoreduced red blood cells from asymptomatic donors who subsequently developed the disease has confirmed existing concerns about the possible spread of transmissible spongiform encephalopathies (TSEs) via blood products. In addition, presence of disease-associated misfolded prion protein (PrPTSE), generally associated with infectivity, has been demonstrated in the blood of vCJD patients. However, its origin and distribution in this biological fluid are still unknown. Various studies have identified cellular prion protein (PrPC) among the protein cargo in human blood-circulating extracellular vesicles (EVs) released from endothelial cells and platelets, and exosomes isolated from the conditioned media of TSE-infected cells have caused the disease when injected into experimental mice. In this study, we demonstrate the detection of PrPTSE in EVs isolated from plasma samples collected during the pre-clinical and clinical phases of the disease from mice infected with mouse-adapted vCJD; and confirm the presence of the exosomal marker Hsp70 in these preparations.